Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Goldberg

Showing results (21-30 of 358) with videos related to

Pageof 36
Sort By:
Cancer Chemotherapy and Pharmacology|August 17, 2004
Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancerRichard M Goldberg, Sharlene Gill
Gastrointestinal Cancer Research : GCR|March 5, 2009
Dealing With Discordance: Managing a Case Where the Patient Looks Better and the CT Scan Looks WorseUsman Shah, Richard M Goldberg
Nature Reviews. Clinical Oncology|June 30, 2009
Cetuximab, chemotherapy and KRAS status in mCRCSharlene Gill, Richard M Goldberg
Clinical Colorectal Cancer|September 17, 2008
Sequential versus combination therapy in the treatment of patients with advanced colorectal cancerUsman Shah, Richard M Goldberg
Expert Opinion on Pharmacotherapy|October 6, 2004
A review of oxaliplatin and its clinical use in colorectal cancerAxel Grothey, Richard M Goldberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Systemic therapy for metastatic colorectal cancer: current options, current evidenceHanna Kelly, Richard M Goldberg
Nature Clinical Practice. Oncology|November 3, 2005
Duration of adjuvant therapy for colorectal cancer: are we overtreating our patients?Sharlene Gill, Richard M Goldberg
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Managing choices for older patients with colon cancer: adjuvant therapyChristina Wu, Richard M Goldberg
Nature Reviews. Gastroenterology & Hepatology|August 29, 2009
Colorectal cancer: Irinotecan therapy-following a trail of breadcrumbs?Richard M Goldberg, Bert H O'Neil
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
An embarrassment of riches: neoadjuvant therapy of rectal cancerJoel E Tepper, Richard M Goldberg
Pageof 36

Showing results (21-30 of 358) with videos related to

Sort By:
Pageof 36
Cancer Chemotherapy and Pharmacology|August 17, 2004
Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancerRichard M Goldberg, Sharlene Gill
Gastrointestinal Cancer Research : GCR|March 5, 2009
Dealing With Discordance: Managing a Case Where the Patient Looks Better and the CT Scan Looks WorseUsman Shah, Richard M Goldberg
Nature Reviews. Clinical Oncology|June 30, 2009
Cetuximab, chemotherapy and KRAS status in mCRCSharlene Gill, Richard M Goldberg
Clinical Colorectal Cancer|September 17, 2008
Sequential versus combination therapy in the treatment of patients with advanced colorectal cancerUsman Shah, Richard M Goldberg
Expert Opinion on Pharmacotherapy|October 6, 2004
A review of oxaliplatin and its clinical use in colorectal cancerAxel Grothey, Richard M Goldberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Systemic therapy for metastatic colorectal cancer: current options, current evidenceHanna Kelly, Richard M Goldberg
Nature Clinical Practice. Oncology|November 3, 2005
Duration of adjuvant therapy for colorectal cancer: are we overtreating our patients?Sharlene Gill, Richard M Goldberg
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Managing choices for older patients with colon cancer: adjuvant therapyChristina Wu, Richard M Goldberg
Nature Reviews. Gastroenterology & Hepatology|August 29, 2009
Colorectal cancer: Irinotecan therapy-following a trail of breadcrumbs?Richard M Goldberg, Bert H O'Neil
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
An embarrassment of riches: neoadjuvant therapy of rectal cancerJoel E Tepper, Richard M Goldberg
Pageof 36